Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Jan 15;313(Pt 2):567–574. doi: 10.1042/bj3130567

Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes.

J D Sparks 1, T L Phung 1, M Bolognino 1, C E Sparks 1
PMCID: PMC1216945  PMID: 8573094

Abstract

Insulin inhibition of the secretion of apolipoprotein B (apo B) was studied in primary cultures of rat hepatocytes by using brefeldin A (BFA), an inhibitor of protein transport from the endoplasmic reticulum (ER) to the Golgi apparatus, and by using the phosphatidylinositol 3-kinase (PI 3-K) inhibitor wortmannin. Incubation of hepatocytes with BFA (10 micrograms/ml) for 1 h inhibited the subsequent secretion of apo B, albumin and transferrin for up to 3 h. BFA treatment resulted in the time-dependent accumulation in cells of [14C]leucine-labelled proteins and apo B. Under conditions where insulin decreased total apo B (cell plus secreted), BFA blocked the insulin-dependent effect. These results suggest that export of apo B from the ER is a prerequisite for the observed insulin effect. Treatment of hepatocytes with wortmannin for 20 min abolished insulin inhibition of apo B secretion, suggesting that the insulin effect on the apo B pathway involves activation of PI 3-K. Enzyme inhibitor studies indicate that chymostatin and (+)-(2S,3S)-3-[(S)-methyl-1-(3-methylbutylcarbamoyl)-butylcarba moyl]-2- oxiranecarboxylate (E-64-c) partially block insulin effects on apo B compared with leupeptin, which had no discernible effect. The cell-permeable derivative of E-64-c, EST, and N-Ac-Leu-Leu-norleucinal (ALLN) were most effective in blocking insulin effects on apo B. These results suggest that insulin action on apo B in primary rat hepatocytes involves (1) vesicular movement of apo B from the ER; (2) activation of PI 3-K and (3) a cellular protease that is either a cysteine- or calcium-activated neutral protease.

Full Text

The Full Text of this article is available as a PDF (497.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Backer J. M., Myers M. G., Jr, Shoelson S. E., Chin D. J., Sun X. J., Miralpeix M., Hu P., Margolis B., Skolnik E. Y., Schlessinger J. Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 1992 Sep;11(9):3469–3479. doi: 10.1002/j.1460-2075.1992.tb05426.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Backer J. M., Schroeder G. G., Kahn C. R., Myers M. G., Jr, Wilden P. A., Cahill D. A., White M. F. Insulin stimulation of phosphatidylinositol 3-kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation. J Biol Chem. 1992 Jan 15;267(2):1367–1374. [PubMed] [Google Scholar]
  3. Björnsson O. G., Duerden J. M., Bartlett S. M., Sparks J. D., Sparks C. E., Gibbons G. F. The role of pancreatic hormones in the regulation of lipid storage, oxidation and secretion in primary cultures of rat hepatocytes. Short- and long-term effects. Biochem J. 1992 Jan 15;281(Pt 2):381–386. doi: 10.1042/bj2810381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Borchardt R. A., Davis R. A. Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion. J Biol Chem. 1987 Dec 5;262(34):16394–16402. [PubMed] [Google Scholar]
  5. Borén J., Rustaeus S., Olofsson S. O. Studies on the assembly of apolipoprotein B-100- and B-48-containing very low density lipoproteins in McA-RH7777 cells. J Biol Chem. 1994 Oct 14;269(41):25879–25888. [PubMed] [Google Scholar]
  6. Carpenter C. L., Auger K. R., Duckworth B. C., Hou W. M., Schaffhausen B., Cantley L. C. A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol Cell Biol. 1993 Mar;13(3):1657–1665. doi: 10.1128/mcb.13.3.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cheatham B., Vlahos C. J., Cheatham L., Wang L., Blenis J., Kahn C. R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol. 1994 Jul;14(7):4902–4911. doi: 10.1128/mcb.14.7.4902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chege N. W., Pfeffer S. R. Compartmentation of the Golgi complex: brefeldin-A distinguishes trans-Golgi cisternae from the trans-Golgi network. J Cell Biol. 1990 Sep;111(3):893–899. doi: 10.1083/jcb.111.3.893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Clarke J. F., Young P. W., Yonezawa K., Kasuga M., Holman G. D. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J. 1994 Jun 15;300(Pt 3):631–635. doi: 10.1042/bj3000631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Corsetti J. P., Way B. A., Sparks C. E., Sparks J. D. Immunolocalization, quantitation and cellular heterogeneity of apolipoprotein B in rat hepatocytes. Hepatology. 1992 Jun;15(6):1117–1124. doi: 10.1002/hep.1840150624. [DOI] [PubMed] [Google Scholar]
  11. Dashti N., Williams D. L., Alaupovic P. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res. 1989 Sep;30(9):1365–1373. [PubMed] [Google Scholar]
  12. Davis R. A., Boogaerts J. R. Intrahepatic assembly of very low density lipoproteins. Effect of fatty acids on triacylglycerol and apolipoprotein synthesis. J Biol Chem. 1982 Sep 25;257(18):10908–10913. [PubMed] [Google Scholar]
  13. Davis R. A., Thrift R. N., Wu C. C., Howell K. E. Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane. Evidence for two functionally distinct pools. J Biol Chem. 1990 Jun 15;265(17):10005–10011. [PubMed] [Google Scholar]
  14. Dhand R., Hiles I., Panayotou G., Roche S., Fry M. J., Gout I., Totty N. F., Truong O., Vicendo P., Yonezawa K. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 1994 Feb 1;13(3):522–533. doi: 10.1002/j.1460-2075.1994.tb06290.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dixon J. L., Furukawa S., Ginsberg H. N. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem. 1991 Mar 15;266(8):5080–5086. [PubMed] [Google Scholar]
  16. Elovson J., Chatterton J. E., Bell G. T., Schumaker V. N., Reuben M. A., Puppione D. L., Reeve J. R., Jr, Young N. L. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res. 1988 Nov;29(11):1461–1473. [PubMed] [Google Scholar]
  17. Fujiwara T., Oda K., Yokota S., Takatsuki A., Ikehara Y. Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J Biol Chem. 1988 Dec 5;263(34):18545–18552. [PubMed] [Google Scholar]
  18. Furukawa S., Sakata N., Ginsberg H. N., Dixon J. L. Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells. J Biol Chem. 1992 Nov 5;267(31):22630–22638. [PubMed] [Google Scholar]
  19. Gotto A. M., Levy R. I., John K., Fredrickson D. S. On the protein defect in abetalipoproteinemia. N Engl J Med. 1971 Apr 15;284(15):813–818. doi: 10.1056/NEJM197104152841503. [DOI] [PubMed] [Google Scholar]
  20. Grinde B., Seglen P. O. Differential effects of proteinase inhibitors and amines on the lysosomal and non-lysosomal pathways of protein degradation in isolated rat hepatocytes. Biochim Biophys Acta. 1980 Sep 17;632(1):73–86. doi: 10.1016/0304-4165(80)90250-0. [DOI] [PubMed] [Google Scholar]
  21. Herman P. K., Emr S. D. Characterization of VPS34, a gene required for vacuolar protein sorting and vacuole segregation in Saccharomyces cerevisiae. Mol Cell Biol. 1990 Dec;10(12):6742–6754. doi: 10.1128/mcb.10.12.6742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Herman P. K., Stack J. H., Emr S. D. An essential role for a protein and lipid kinase complex in secretory protein sorting. Trends Cell Biol. 1992 Dec;2(12):363–368. doi: 10.1016/0962-8924(92)90048-r. [DOI] [PubMed] [Google Scholar]
  23. Hiles I. D., Otsu M., Volinia S., Fry M. J., Gout I., Dhand R., Panayotou G., Ruiz-Larrea F., Thompson A., Totty N. F. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell. 1992 Aug 7;70(3):419–429. doi: 10.1016/0092-8674(92)90166-a. [DOI] [PubMed] [Google Scholar]
  24. Hsu V. W., Shah N., Klausner R. D. A brefeldin A-like phenotype is induced by the overexpression of a human ERD-2-like protein, ELP-1. Cell. 1992 May 15;69(4):625–635. doi: 10.1016/0092-8674(92)90226-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kane J. P. Apolipoprotein B: structural and metabolic heterogeneity. Annu Rev Physiol. 1983;45:637–650. doi: 10.1146/annurev.ph.45.030183.003225. [DOI] [PubMed] [Google Scholar]
  26. Kelly K. L., Ruderman N. B., Chen K. S. Phosphatidylinositol-3-kinase in isolated rat adipocytes. Activation by insulin and subcellular distribution. J Biol Chem. 1992 Feb 15;267(5):3423–3428. [PubMed] [Google Scholar]
  27. Kelly K. L., Ruderman N. B. Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. J Biol Chem. 1993 Feb 25;268(6):4391–4398. [PubMed] [Google Scholar]
  28. Klausner R. D., Donaldson J. G., Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol. 1992 Mar;116(5):1071–1080. doi: 10.1083/jcb.116.5.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  30. Lam K., Carpenter C. L., Ruderman N. B., Friel J. C., Kelly K. L. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. J Biol Chem. 1994 Aug 12;269(32):20648–20652. [PubMed] [Google Scholar]
  31. Lewis G. F., Uffelman K. D., Szeto L. W., Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes. 1993 Jun;42(6):833–842. doi: 10.2337/diab.42.6.833. [DOI] [PubMed] [Google Scholar]
  32. Markwell M. A., Haas S. M., Bieber L. L., Tolbert N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978 Jun 15;87(1):206–210. doi: 10.1016/0003-2697(78)90586-9. [DOI] [PubMed] [Google Scholar]
  33. Mehdi S. Cell-penetrating inhibitors of calpain. Trends Biochem Sci. 1991 Apr;16(4):150–153. doi: 10.1016/0968-0004(91)90058-4. [DOI] [PubMed] [Google Scholar]
  34. Moir A. M., Zammit V. A. Monitoring of changes in hepatic fatty acid and glycerolipid metabolism during the starved-to-fed transition in vivo. Studies on awake, unrestrained rats. Biochem J. 1993 Jan 1;289(Pt 1):49–55. doi: 10.1042/bj2890049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Okada T., Kawano Y., Sakakibara T., Hazeki O., Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem. 1994 Feb 4;269(5):3568–3573. [PubMed] [Google Scholar]
  36. Patsch W., Franz S., Schonfeld G. Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest. 1983 May;71(5):1161–1174. doi: 10.1172/JCI110865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Patsch W., Gotto A. M., Jr, Patsch J. R. Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor. J Biol Chem. 1986 Jul 25;261(21):9603–9606. [PubMed] [Google Scholar]
  38. Patsch W., Tamai T., Schonfeld G. Effect of fatty acids on lipid and apoprotein secretion and association in hepatocyte cultures. J Clin Invest. 1983 Jul;72(1):371–378. doi: 10.1172/JCI110977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pullinger C. R., North J. D., Teng B. B., Rifici V. A., Ronhild de Brito A. E., Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res. 1989 Jul;30(7):1065–1077. [PubMed] [Google Scholar]
  40. Rusiñol A. E., Chan E. Y., Vance J. E. Movement of apolipoprotein B into the lumen of microsomes from hepatocytes is disrupted in membranes enriched in phosphatidylmonomethylethanolamine. J Biol Chem. 1993 Nov 25;268(33):25168–25175. [PubMed] [Google Scholar]
  41. Rusiñol A. E., Vance J. E. Inhibition of secretion of truncated apolipoproteins B by monomethylethanolamine is independent of the length of the apolipoprotein. J Biol Chem. 1995 Jun 2;270(22):13318–13325. doi: 10.1074/jbc.270.22.13318. [DOI] [PubMed] [Google Scholar]
  42. Sakata N., Wu X., Dixon J. L., Ginsberg H. N. Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells. J Biol Chem. 1993 Nov 5;268(31):22967–22970. [PubMed] [Google Scholar]
  43. Salhanick A. I., Schwartz S. I., Amatruda J. M. Insulin inhibits apolipoprotein B secretion in isolated human hepatocytes. Metabolism. 1991 Mar;40(3):275–279. doi: 10.1016/0026-0495(91)90109-a. [DOI] [PubMed] [Google Scholar]
  44. Sato R., Imanaka T., Takatsuki A., Takano T. Degradation of newly synthesized apolipoprotein B-100 in a pre-Golgi compartment. J Biol Chem. 1990 Jul 15;265(20):11880–11884. [PubMed] [Google Scholar]
  45. Shepherd P. R., Navé B. T., Siddle K. Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem J. 1995 Jan 1;305(Pt 1):25–28. doi: 10.1042/bj3050025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sparks C. E., Sparks J. D., Bolognino M., Salhanick A., Strumph P. S., Amatruda J. M. Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes. Metabolism. 1986 Dec;35(12):1128–1136. doi: 10.1016/0026-0495(86)90026-0. [DOI] [PubMed] [Google Scholar]
  47. Sparks J. D., Bolognino M., Trax P. A., Sparks C. E. The production and utility of monoclonal antibodies to rat apolipoprotein B lipoproteins. Atherosclerosis. 1986 Sep;61(3):205–211. doi: 10.1016/0021-9150(86)90139-5. [DOI] [PubMed] [Google Scholar]
  48. Sparks J. D., Corsetti J. P., Sparks C. E. Liver regrowth and apolipoprotein B secretion by rat hepatocytes following partial hepatectomy. Metabolism. 1994 Jun;43(6):681–690. doi: 10.1016/0026-0495(94)90115-5. [DOI] [PubMed] [Google Scholar]
  49. Sparks J. D., Sparks C. E. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem. 1990 May 25;265(15):8854–8862. [PubMed] [Google Scholar]
  50. Sparks J. D., Sparks C. E. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim Biophys Acta. 1994 Nov 17;1215(1-2):9–32. doi: 10.1016/0005-2760(94)90088-4. [DOI] [PubMed] [Google Scholar]
  51. Sparks J. D., Sparks C. E. Obese Zucker (fa/fa) rats are resistant to insulin's inhibitory effect on hepatic apo B secretion. Biochem Biophys Res Commun. 1994 Nov 30;205(1):417–422. doi: 10.1006/bbrc.1994.2681. [DOI] [PubMed] [Google Scholar]
  52. Sparks J. D., Sparks C. E., Roncone A. M., Amatruda J. M. Secretion of high and low molecular weight phosphorylated apolipoprotein B by hepatocytes from control and diabetic rats. Phosphorylation of APO BH and APO BL. J Biol Chem. 1988 Apr 15;263(11):5001–5004. [PubMed] [Google Scholar]
  53. Sparks J. D., Zolfaghari R., Sparks C. E., Smith H. C., Fisher E. A. Impaired hepatic apolipoprotein B and E translation in streptozotocin diabetic rats. J Clin Invest. 1992 May;89(5):1418–1430. doi: 10.1172/JCI115731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Stack J. H., Emr S. D. Vps34p required for yeast vacuolar protein sorting is a multiple specificity kinase that exhibits both protein kinase and phosphatidylinositol-specific PI 3-kinase activities. J Biol Chem. 1994 Dec 16;269(50):31552–31562. [PubMed] [Google Scholar]
  55. Tamai M., Matsumoto K., Omura S., Koyama I., Ozawa Y., Hanada K. In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64. J Pharmacobiodyn. 1986 Aug;9(8):672–677. doi: 10.1248/bpb1978.9.672. [DOI] [PubMed] [Google Scholar]
  56. Vance J. E., Aasman E. J., Szarka R. Brefeldin A does not inhibit the movement of phosphatidylethanolamine from its sites for synthesis to the cell surface. J Biol Chem. 1991 May 5;266(13):8241–8247. [PubMed] [Google Scholar]
  57. White M. F., Kahn C. R. The insulin signaling system. J Biol Chem. 1994 Jan 7;269(1):1–4. [PubMed] [Google Scholar]
  58. Wiggins D., Hems R., Gibbons G. F. Decreased sensitivity to the inhibitory effect of insulin on the secretion of very-low-density lipoprotein in cultured hepatocytes from fructose-fed rats. Metabolism. 1995 Jul;44(7):841–847. doi: 10.1016/0026-0495(95)90235-x. [DOI] [PubMed] [Google Scholar]
  59. Wilcox D., Mason R. W. Inhibition of cysteine proteinases in lysosomes and whole cells. Biochem J. 1992 Jul 15;285(Pt 2):495–502. doi: 10.1042/bj2850495. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES